AnemInject Rompharm, 50 mg/ml dispersion for injection/infusion 

AnemInject Rompharm is indicated for the treatment of iron deficiency when:

·  oral iron preparations are ineffective. 

·  oral iron preparations cannot be used. 

·  there is a clinical need to deliver iron rapidly.

AnemInject Rompharm dispersion for injection/infusion is a colloidal solution of the iron complex ferric carboxymaltose. The complex is designed to provide, in a controlled way, utilisable iron for the iron transport and storage proteins in the body (transferrin and ferritin, respectively). Red cell utilisation of ⁵⁹Fe from radio-labelled ferric carboxymaltose ranged from 91% to 99% in subjects with iron deficiency (ID) and 61% to 84% in subjects with renal anaemia at 24 days post-dose. Ferric carboxymaltose treatment results in an increase in reticulocyte count, serum ferritin levels and TSAT levels to within normal ranges.